FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...
The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration. The approval makes FluMist the only 'flu vaccine in ...
If you have a fear of needles and are nervous about getting the flu shot, you’re not alone. It’s estimated that up to 25% of adults have a strong fear of needles. Enter FluMist, the nasal flu vaccine.
Those looking to protect themselves against the flu this season now have an at-home option. FluMist, the only nasal spray flu vaccine approved by the Food and Drug Administration, is now available for ...
Eligible individuals will be able to have the vaccine shipped to their homes for self-administration. The Food and Drug Administration (FDA) has approved at-home self- or caregiver-administration of ...